Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension

    Not Recruiting
  • End date
    May 24, 2022
  • participants needed
  • sponsor
    JIMRO Co., Ltd.
Updated on 26 January 2021
Yoshimi Tsuchimoto, Otsuka RDN Project
Primary Contact
(0.0 mi away) Contact
+52 other location
resistant hypertension


The REQUIRE STUDY is a multi-center, randomized, double-blind, sham-controlled study, which aims to confirm the efficacy and safety of PRDS-001 (ReCor Medical Inc. Paradise in Europe) for renal denervation therapy in patients with treatment resistance hypertension, in comparison with the sham procedure.


Patients with treatment resistance hypertension is defined patients being treated on 3 or more different classes of antihypertensive medications including diuretics.

Condition Vascular Diseases, Hypertension, Cardiovascular Disease, Diabetes and Hypertension, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric)
Treatment Sham Procedure, PRDS-001 Renal Denervation Ultrasound System
Clinical Study IdentifierNCT02918305
SponsorJIMRO Co., Ltd.
Last Modified on26 January 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note